CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion

Journal of Experimental Medicine

Volumn 185, Issue 7, 1997, Pages 1327-1335

  Wu, Yan ^a   Guo, Yong ^a   Huang, Andy ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; CHO CELL; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CHO CELLS; CRICETINAE; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0030902622     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.7.1327     Document Type: Article

References (46)

1. Brestcher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science (Wash. DC). 169:1042-1049.
2. Lafferry, K.J., S.J. Prowse, C.J. Simeonovich, and H.S. Warren. 1983. Immunobiology of tissue transplantation: a return to passenger leukocyte concept. Annu. Rev. Immunol. 1: 143-173.
3. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion vs functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen occupancy. Annu. Rev. Immunol. 7:445-480.
4. Liu, Y., and P.S. Linsley. 1992. T cell costimulation. Curr. Opin. Immunol. 4:265-270.
5. Linsley, P.S., E.A. Clark, and J.A. Ledbetter. 1990. The T cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen B7. Proc. Natl. Acad. Sci. USA. 87:5031-5035.
6. Linsley, P.S., W. Brady , L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med. 173: 721-730.
7. Linsley, P.S., W. Brady, L. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for B cell activation antigen B7. J. Exp. Med. 174:561-569.
8. Linsley, P.S., J.L. Green, W. Brady, J. Bajorath, J.A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) binds with similar avidity but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:793-801.
9. Walunas, T.L., D.J. Lenchow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1995. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-414.
10. Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-466.
11. Linsley, P.S., J.A. Green, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Co-expression and functional co-operation of CTLA-4 and CD28 on activated T lymphocyte. J. Exp. Med. 176:1595-1604.
12. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylmositol-3-OH kinase to CD28 is required for T cell signalling. Nature (Lond.). 369:327-329.
13. August, A., and B. DuPont. 1994. CD28 of T lymphocytes associates with the phosphatidylinositol-3-OH kinase. Int. Immunol. 6:769-774.
14. Prasad, K.V., Y.C. Cai, M. Raab, B. Dukeworth, L. Cantley, S.E. Shoelson, and C.E. Rudd. 1994. T cell antigen CD28 interacts with the lipid kinase phosphatidylinositol-3-OH kinase by a cytoplasmic Tyr (p)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA. 91:2834-2838.
15. Truitt, K.E., C.M. Hicks, and J.B. Imboden. 1994. Stimulation of CD28 triggers an association of between CD28 and phosphatidylinositol-3-OH kinase in Jurkat T cells. J. Exp. Med. 179:1071-1076.
16. Schneider, H., Y.C. Cai, K.V.S. Pradad, S.E. Shoelson, and C.E. Rudd. 1995. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181:351-355.
17. Marengere, L.E., P. Waterhouse, G.S. Duncan, H.W. Mittrucker, G.S. Feng, and T.W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science (Wash. DC). 272:1170-1173.
18. Waterhouse, P., J.M. Penninger, E. Yimms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science (Wash. DC). 270:985-987.
19. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
20. Krummel, M.F., and J.P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533-2540.
21. Walnunas, T.L., C.Y. Bakker, and J.A. Bluestone. 1996. CTLA-4-ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541-2550.
22. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032-1036.
23. Karandikar, N.J., C.L. Vanderlugt, T.L. Walunas, S.D. Miller, and J.A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783-788.
24. Leach, D.R., M.F. Krummel, and J.P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science (Wash. DC). 271:1734-1736.
25. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
26. Shahinian, A., K. Pfeffer, K.P. Lee, K.P. Kundig, T.M. Kishihara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science (Wash. DC). 261: 609-612.
27. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody against murine T 3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1037-1041.
28. Razi-Wolf, Z., G.J. Freeman, F. Galvin, B. Benacerraf, L.M. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cell. Proc. Natl. Acad. Sci. USA. 89:4210-4214.
29. Wu, Y., Y. Guo, and Y. Lui. 1993. A major co-stimulatory molecule, CTLA-4 ligand A, is distinct from B7. J. Exp. Med. 178:1789-1793.
30. Bottomly, K., M. Luqman, L. Greenbaum, S. Carding, J. West, T. Pasqualini, and D. Murphy. 1989. A monoclonal antibody to murine CD45R distinguish CD4 T cell population that produce different cytokines. Eur. J. Immunol. 19: 617-623.
31. Metlay, J.P., M.D. Witmer-Pack, R. Agger, M.T. Crowley, D.S. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753-1763.
32. Guo, Y., Y. Wu, M. Zhao, X.P. Kong, and Y. Liu. 1995. Mutational analysis of an alternatively spliced product of B7 defines its CD28/CTLA-4-binding site on Immunoglobulin C-like domain. J. Exp. Med. 181:1345-1355.
33. Aruffo, A., and B. Seed. 1987. Molecular cloning of CD28 cDNA through a high efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA. 84:8573-8577.
34. Liu, Y., B. Jones, A. Aruffo, K.M. Sullivan, P.S. Linsley, and C.A. Janeway, Jr. 1992. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:437-445.
35. Wu, Y., J. Xu, S. Shinde, I. Grewal, T. Henderson, R.A. Flavell, and Y. Liu. 1995. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 5: 1303-1311.
36. Guo, Y., Y. Wu, S. Shinde, M.-S. Sy, A. Aruffo, and Y. Liu. 1996. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 184:955-961.
37. Fargeas, C.A., A. Truneh, M. Reddy, M. Hurle, R. Sweet, and R.-P. Sekaly. 1995. Identification of residues in V-domain of CD80 (B7-1) implicated in functional interaction with CD28 and CTLA-4. J. Exp. Med. 182:667-676.
38. Peach, R., J. Bajorath, J. Naemura, G. Leytze, J.-A. Green, A. Aruffo, and P.S. Linsley. 1995. Both extracellular immunoglobulin-like domains of CD80 contains residues critical for binding T cell surface receptor CTLA-4 and CD28. J. Biol. Chem. 270:21181-21187.
39. Hara, T., S.M. Fu, and J.A. Hansen. 1985. Human T cell activation II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44-kilodalton peptide (9.3 antigen). J. Exp. Med. 161:1513-1524.
40. Moretta, A., G. Pantaleo, M. Lopez-Botet, and L. Moratta. 1985. Involvement of T44 molecule in an antigen-independent pathway of T cell activation. J. Exp. Med. 162:823-838.
41. June, C.H., J.A. Ledbetter, M.M. Gillispie, T. Linsten, and C.B. Thompson. 1987. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant IL-2 gene expression. Mol. Cell Biol. 7:4472-4481.
42. Harding, F., J. McAuther, J.A. Gross, and J.P. Allison. 1992. CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cells. Nature (Lond.). 356: 607-609.
43. Jenkins, M.K., P.S. Taylor, K.B. Urdahl, and S.D. Norton. 1991. CD28 delivers costimulatory signals involved in antigen-specific IL-2 production by human T cells and prevents anergy. J. Immunol. 147:2461-2466.
44. Lui, Y., and C.A. Janeway, Jr. 1992. Cells that present both specific ligand and costimulatory activity are the most efficient inducer of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA. 89:3845-3849.
45. Chambers, B.J., M. Salcedo, and H.-G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 5:311-317.
46. Linsley, P.S., J. Bradshaw, J. Greene, R. Peach, K.L. Bennett, and R.S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity. 4:535-543.